AIM
RCEL icon

Aigen Investment Management’s Avita Medical RCEL Stock Holding History

Aigen Investment Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,005
Closed -$220K – 952
2023
Q4 		$220K Buy
+16,005
New +$183K 0.04% 631

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Aigen Investment Management's RCEL Position: Q1 2024 in Review

Aigen Investment Management sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 16,005 shares — an estimated $220K sold.

Aigen Investment Management first reported a position in RCEL in Q4 2023 and held it in 1 quarter. The position peaked at $220K in Q4 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Aigen Investment Management reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
  • Aigen Investment Management sold 16,005 Avita Medical shares in Q1 2024, an estimated $220K.
  • Aigen Investment Management first reported a position in Avita Medical in Q4 2023 and held it in 1 quarter.
  • Aigen Investment Management's Avita Medical position peaked at $220K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.